Skip to content

Adult Primary and Preventive Practice (APPP) Study

Adult Primary and Preventive Practice (APPP) Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02915653
Acronym
APPP
Enrollment
213
Registered
2016-09-27
Start date
2016-09-30
Completion date
2017-11-30
Last updated
2018-06-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Preventive Care

Brief summary

The study is a pre-post two round, randomized controlled study design of PCPs randomly assigned to a control or 1 of 2 intervention arms.

Interventions

OTHEREducational materials on a new diagnostic service

Educational materials on a new diagnostic service

Sponsors

Applied Proteomics Inc
CollaboratorUNKNOWN
Qure Healthcare, LLC
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* 1\. Provide consent to participate in the study 2. Board-certified physician currently practicing in the following areas: 3. Internal medicine 4. Family medicine 5. Have practiced as a board-certified physician in internal or family medicine for greater than 2 but less than 30 years. 6. English-speaking 7. Community / non-academic based practice setting 8. ≥ 40 patients under care weekly 9. Access to the internet

Exclusion criteria

* 1\. Not board certified in their respective area of care 2. Academic-based practice 3. Have practiced as a board-certified physician for less than 2 or greater than 30 years 4. Follow \<40 patients weekly 5. Non-English speaking 6. Unable to access the internet

Design outcomes

Primary

MeasureTime frameDescription
Quality of Care8 weeksDifference in difference of combined diagnostic and treatment CPV domain scores, including colonoscopy referral rates, in post-intervention versus baseline comparing intervention and control groups among the three patient types.

Secondary

MeasureTime frameDescription
Intervention Impact on Care8 weeksDifference in difference between the control and intervention groups in the overall quality of care for CRC screening and for adult primary prevention care measured by the combined and individual item CPV scores for the three patient types.
Healthcare Utilization8 weeksDifference in health care utilization and/or costs in patients tested with SimpliPro Colon™ versus the control group.
Diagnostic Method Comparison8 weeksDifference in recommendation of CRC evaluation with colonoscopy and/or flexible sigmoidoscopy, double barium enema, or CT colonography, including risk-level and urgency pre- and post-intervention, between intervention and control groups

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026